This notification is provided to you pursuant to Texas Labor Code Section 408.0281(d) "Notification to Health Care Provider" and contains the information we may elect to provide to any person, other than an injured employee, to whom access has been provided to the contractual fee arrangement that National Pharmaceutical Service (NPS) has with you. This applies to contractual fee arrangements for services through the NPS network at rates inconsistent with the Texas workers’ compensation pharmacy fee guidelines. National Pharmaceutical Services is contracted with the following Texas Carriers for the time periods listed below allowing each access to the contractual fee arrangement with you:

On June 28, 2016, Trividia Health announced a recall of certain lots of TRUEread, TRUEbalance, TRUEtrack, and TRUEtest blood glucose test strips because of open test strip vials within the sealed test strip vial boxes.

Please be informed that the MedImpact program of covering the brand version of CRESTOR over generic ROSUVASTATIN CALCIUM ended on July 8, 2016 for Commercial and Marketplace clients. The program will continue for Medicare Part D clients.

As a result of the Kansas Department of Health and Environment’s (KDHE) Payment Reduction policy and effective July 1, 2016, Sunflower Health Plan will reduce Medicaid provider reimbursements for dates of service on and after July 1, 2016.

This week's update includes information on opioid legislation in Congress, A TRICARE pharmacy pilot, an AMP Final Rule from CMS, and more.